MyCelx Technologies Corporation Director/PDMR Shareholding (8508R)

TIDMMYX TIDMTTM

RNS Number : 8508R

MyCelx Technologies Corporation

09 November 2021

9 November 2021

Mycelx Technologies Corporation

("Mycelx" or the "Company" (AIM: MYX)

Dealing by Director

The Company announces that it was notified on 9 November 2021 by Connie Mixon, Chief Executive Officer and a Director of the Company, that on 9 November 2021 she purchased 24,000 Common Shares at a price of GBP0.60 per Common Share. Following this transaction, she continues to be interested in 2,514,469 Common Shares representing 12.93 per cent of the present issued capital of the Company and in 413,017 options over the Company's Common Shares.

The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; (b) 202,646 shares held by or on behalf of Ms. Mixon's children; and (c) 10,000 shares which are held by the estate of her late husband Mark Mixon as a custodian.

For further information please contact:

 
MYCELX Technologies Corporation 
 Connie Mixon, CEO                      Tel: [phone] 
 Kim Slayton, CFO 
Canaccord Genuity, Nominated Adviser 
 Henry Fitzgerald-O'Connor              Tel: + 44 20 7523 8000 
 Georgina McCooke 
Celicourt 
 Mark Antelme                           Tel: [phone] 
 Jimmy Lea 
 

Notification of transactions of persons discharging managerial responsibility or connected persons

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                          Connie Mixon 
     ----------------------------  ---------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status               Director 
     ----------------------------  ---------------------------------- 
 b)   Initial notification          Initial notification 
       /Amendment 
     ----------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                          Mycelx Technologies Corporation 
     ----------------------------  ---------------------------------- 
 b)   LEI                           213800UJZINIK2VD1G48 
     ----------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where 
       transactions have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of the 
       financial instrument,          Common shares of US$0.025 
       type of instrument 
 
       Identification code            USU624551078 
     ----------------------------  ---------------------------------- 
 b)   Nature of the transaction     Purchase of Common Shares 
     ----------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)          Price(s)    Volume(s) 
 
                                        GBP0.60     24,000 
                                                  ---------- 
     ----------------------------  ---------------------------------- 
 d)   Aggregated information 
 
 
       - Aggregated volume            n/a 
 
 
       - Price                        n/a 
     ----------------------------  ---------------------------------- 
 e)   Date of the transaction       9/11/2021 
     ----------------------------  ---------------------------------- 
 f)   Place of the transaction      London Stock Exchange 
     ----------------------------  ---------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVRLALAIIL

(END) Dow Jones Newswires

November 09, 2021 11:42 ET (16:42 GMT)